Costing report: menopause diagnosis and management

"This report focuses on the recommendations that are considered to have the greatest resource impact nationally, and therefore need the most additional resources to implement or can potentially generate the biggest savings. They are:

- decrease the number of follicle-stimulating hormone (FSH) tests in women 
- increase use of transdermal hormone replacement therapy (HRT). "

Costing report: menopause diagnosis and management 
Implementing the NICE guideline on menopause (NG23)
NICE
November 2015

Read more here.

Direct costs of radiotherapy for rectal cancer

"Traditional radiotherapy for rectal cancer is relatively inexpensive. Moreover, significant savings may be achievable through service organization and provision changes. These results suggest that a strong economic argument can be made for expanding the use of radiotherapy in rectal cancer treatment."

Direct costs of radiotherapy for rectal cancer: a microcosting study

P Hanly, A Ó Céilleachair, M Skally, C O’Neill, L Sharp
BMC Health Services Research 2015, 15:184  doi:10.1186/s12913-015-0845-9

Read more here.

Multiple sclerosis (relapsing remitting) - dimethyl fumarate: costing report

"The costing template can be used by health communities to assess the local impact of implementing the recommendations, based on the local population. The national assumptions used in the template can be altered to reflect local circumstances."

TA320 Multiple sclerosis (relapsing remitting) - dimethyl fumarate: costing report
NICE
August 2014

Read more here.